Tag: NfL

10 Kaggle Competitions Every Young Data Scientist Should Check Out

Unlike high school lessons and exams, competitions can offer some much-needed practical experience. Participating in data science competitions not only allows you to hone your coding and analytical skills but also provides hands-on experience in tackling real-world problems. These competitions act as a dynamic playground where you can put your…

Continue Reading 10 Kaggle Competitions Every Young Data Scientist Should Check Out

Lee’s Famous Recipe Chicken to clone voices with AI for drive-thru

Lee’s Famous Recipe Chicken is using AI at the drive-thru. A quick-serve chicken chain will personalize the drive-thru experience with help from artificial intelligence (AI) – and the voice of a local football legend. Ohio-based Lee’s Famous Recipe Chicken, which operates more than 130 locations in 12 U.S. states and…

Continue Reading Lee’s Famous Recipe Chicken to clone voices with AI for drive-thru

In Vitro Diagnostics Market Size Estimated to Reach USD 124.65 Bn by 2032| Precedence Research

OTTAWA, ON, Dec. 8, 2023 /PRNewswire/ — The global in vitro diagnostics (IVD) market size is estimated to reach around USD 124.65 billion by 2032, increasing from USD 107.76 billion in 2023. The global in vitro diagnostics (IVD) market size was estimated at USD 115.48 billion in 2022 and the sector has…

Continue Reading In Vitro Diagnostics Market Size Estimated to Reach USD 124.65 Bn by 2032| Precedence Research

BTK Inhibitor Evobrutinib Fails to Meet Primary End Points in Phase 3 EVOLUTION Trials

According to an announcement, evobrutinib (Merck KGaA/EMD Serono), an investigational Bruton’s tyrosine kinase (BTK) inhibitor in development for patients with multiple sclerosis (MS), did not meet its primary end points of reducing relapse in the phase 3 EVOLUTION trials. The company plans to evaluate the totality of the data for…

Continue Reading BTK Inhibitor Evobrutinib Fails to Meet Primary End Points in Phase 3 EVOLUTION Trials

Sports is only starting to imagine, and experience, the capabilities of generative AI. Will organizations bear the cost?

The PGA Tour demonstrated its generative AI virtual assistant at the Pro Am for Amazon’s re:Invent event in Las Vegas in late November. A video clip was generated after the AI assistant answered a question. Then the player would attempt to replicate the shot.Amazon The introduction of ChatGPT a year…

Continue Reading Sports is only starting to imagine, and experience, the capabilities of generative AI. Will organizations bear the cost?

FOX Sports expands Google Cloud partnership, generative AI to automate archived sports video search

Over the past nearly three decades, Fox Sports, a unit of Fox Corp., parent company of Fox News and Fox Business, has amassed countless amounts of video footage. Millions of hours of game-related content exist in vast archives. At any given time, various individuals are tasked with sorting through the…

Continue Reading FOX Sports expands Google Cloud partnership, generative AI to automate archived sports video search

FOX Sports teams with Google Cloud to enhance viewer experience with generative AI

Over the past nearly three decades, FOX Sports, a unit of FOX Corp., parent to Fox News and FOX Business, has accumulated a countless amount of video footage. Millions of hours’ worth of sports-related content live within vast archives. At any given time, various individuals have been tasked with sorting…

Continue Reading FOX Sports teams with Google Cloud to enhance viewer experience with generative AI

BioVie: Upcoming Phase 3 Readout In Alzheimer’s May Create Significant Value (NASDAQ:BIVI)

nantakorn jeenpueng Thesis BioVie (NASDAQ:BIVI), currently valued by the market at about $120 million, is about to report topline data from a Phase 3 study in Alzheimer’s disease [AD] between Thanksgiving and early December. In my previous coverage, I had argued that the baseline data in about 75% of patients…

Continue Reading BioVie: Upcoming Phase 3 Readout In Alzheimer’s May Create Significant Value (NASDAQ:BIVI)

Georgia Couple Arrested Decades After 5-Year-Old Girl Was Found

by Cedric ‘BIG CED’ Thornton November 14, 2023 Officials arrested Evelyn Odom and Ulyster Sanders of Georgia, 35 years after the woman’s daughter was discovered in concrete. A Georgia couple has been arrested and charged with murder after authorities found the body of the woman’s daughter, who died almost 35…

Continue Reading Georgia Couple Arrested Decades After 5-Year-Old Girl Was Found

papain family cysteine protease containing protein, maker-scaffold1702_size30647-snap-gene-0.14 (gene) Tigriopus kingsejongensis

Associated RNAi Experiments Homology BLAST of papain family cysteine protease containing protein vs. L. salmonis genes Match: EMLSAG00000006045 (supercontig:LSalAtl2s:LSalAtl2s327:400616:404607:-1 gene:EMLSAG00000006045 transcript:EMLSAT00000006045 description:”augustus_masked-LSalAtl2s327-processed-gene-4.0″) HSP 1 Score: 590.497 bits (1521), Expect = 0.000e+0Identity = 283/525 (53.90%), Postives = 368/525 (70.10%), Query Frame = 0 Query: 49 GHVARPLGKSPPNFVRDPPPRTTPPAQWLWNNVNETNFLTVSRNQHLPTYCGSCWAHAATSSLSDRIKIARQGAWPDINLAPQVLISCGPGDGCHGGEAGDANAYMHAQGITDETCSIYRARGQDNGLPCSKLEICSTCE—SKCYQPQHFFTYRVDEFHDVEGESNGEQEANMMAEIHHRGPISCGIAVTQALV-NYTGGLFHDKTGAQEIDHDISVVGYGVDEGTQEKYWLIRNSWGTYWGEQGFFRLIRGVNNLGIESGTCSWATPADTWSDAARE—RAAILSNEITLQKP——LWKQLWTVVADFVDNTRDTDLFRRLKLMQKGCKKLSSPRVPVVNIRPRPQDYVSTADLPEALDWRSVNGTNFLSWSVNQHLPVYCGSCWAQAGLSSLADRFTIADRKRFANLALSVQYILNCQAGGSCHGGDAFPLYAFIQKQGVPDVTCQPYEALDEGPLTDCSKPSKLVCKDCTWPPPEPGQEGNCWAKEKFHRYYVDEYNGVEGADNMKKEILERGPVT 560 GH+ R G+…

Continue Reading papain family cysteine protease containing protein, maker-scaffold1702_size30647-snap-gene-0.14 (gene) Tigriopus kingsejongensis

Alphabet Inc. (NASDAQ:GOOG) Q3 2023 Earnings Call Transcript

Alphabet Inc. (NASDAQ:GOOG) Q3 2023 Earnings Call Transcript October 24, 2023 Operator: Welcome, everyone. Thank you for standing by for the Alphabet Third Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] I…

Continue Reading Alphabet Inc. (NASDAQ:GOOG) Q3 2023 Earnings Call Transcript

Q3 2023 Alphabet Inc Earnings Call

Participants James H. Friedland; Director of IR; Alphabet Inc. Philipp Schindler; Senior VP & Chief Business Officer; Google LLC Ruth M. Porat; President, CIO, Senior VP & CFO; Alphabet Inc. Sundar Pichai; CEO & Director; Alphabet Inc. Brian Thomas Nowak; Research Analyst; Morgan Stanley, Research Division Douglas Till Anmuth; MD;…

Continue Reading Q3 2023 Alphabet Inc Earnings Call

California man found dead in 80s in Arizona desert ID’d: Virgil Renner

Authorities in Arizona have identified the remains of a California man found dead four decades ago in a vast desert area along Route 66. Advanced DNA testing allowed the Mohave County Sheriff’s Office to conclude that the remains were those of Virgil R. Renner, who was found in September 1982…

Continue Reading California man found dead in 80s in Arizona desert ID’d: Virgil Renner

CMTA Awards $225,483 for Study On Using ASOs to Treat CMT2E

The Charcot-Marie-Tooth Association (CMTA) Board of Directors announced Sept. 28 that it has approved a $225,483 award to Dr. Mario Saporta at the University of Miami for a study on the use of antisense oligonucleotides (ASOs) to treat CMT2E. CMT is one of the most commonly inherited peripheral neuropathies, affecting…

Continue Reading CMTA Awards $225,483 for Study On Using ASOs to Treat CMT2E

BioVie Announces Completion of Last Patient Treatment Visit in Phase 3 Trial of NE3107 in Mild to Moderate Alzheimer’s Disease

Expects to announce topline data expected in the November/December timeframe. Enrolled patients had underlying medical conditions that are known risk factors for dementia that NE3107 has the potential to improve. /EIN News/ — CARSON CITY, Nev., Sept. 26, 2023 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”)…

Continue Reading BioVie Announces Completion of Last Patient Treatment Visit in Phase 3 Trial of NE3107 in Mild to Moderate Alzheimer’s Disease

BioVie Inc Concludes Phase 3 Clinical Trial of NE3107 in Alzheimers Disease Patients

On September 26, 2023, BioVie Inc. successfully concluded the final patient treatment visit for its groundbreaking Phase 3 clinical trial of NE3107 in individuals suffering from mild to moderate Alzheimer’s Disease. This comprehensive study, encompassing 316 to 400 patients, aimed to evaluate the efficacy of NE3107 in improving cognitive function…

Continue Reading BioVie Inc Concludes Phase 3 Clinical Trial of NE3107 in Alzheimers Disease Patients

BioVie to announce topline data from Phase 3 Alzheimer’s Disease trial by year-end

BioVie Inc (NASDAQ:BIVI) said the last patient has completed their final visit at week 30 in their Phase 3 study of investigational therapy NE3107 in patients with mild to moderate Alzheimer’s Disease (AD), and it expects to announce topline data from the trial in November or December. BioVie’s shares moved higher…

Continue Reading BioVie to announce topline data from Phase 3 Alzheimer’s Disease trial by year-end

Buffalo Niagara Business, What’s New This Week

During August, the Buffalo Niagara job market went into reverse, with 5,300 jobs lost when kids returned to school.  When the state Labour Department releases its newest figures on Tuesday, we’ll find out if that affected the region’s unemployment rate.  The University at Buffalo’s Blackstone LaunchPad student entrepreneurship program is…

Continue Reading Buffalo Niagara Business, What’s New This Week

The Real Story Behind ARK Investment and Her $250 Million Empire

From leading Wall Street firms to becoming one of the most celebrated female fund managers, Cathie Wood’s journey is anything but ordinary. Whether you’re a budding investor or a seasoned pro, you might want to take some notes. With an estimated net worth of $250 million, Wood’s opinions on the…

Continue Reading The Real Story Behind ARK Investment and Her $250 Million Empire

What is parameter efficient tuning? #GenerativeAI

Large language models such as Bard or Chat GPT can help you increase productivity. Watch along and learn what parameter efficient tuning is and how it can retrain a model on a new domain specific dataset. A guide to parameter-efficient fine-tuning → goo.gle/3NwFoPn Duration: 00:00:41Publisher: Google CloudYou can watch this…

Continue Reading What is parameter efficient tuning? #GenerativeAI

rpubs – Avseetvr

Easy web publishing from R. Write R Markdown documents in RStudio. Share them here on RPubs. (It’s free, and couldn’t be simpler!)Rpubs is an open publishing platform for HTML documents produced using RMarkdown from within RStudio, it provides a simple way to host and share your …Getting Started with RPubs. RStudio…

Continue Reading rpubs – Avseetvr

13 Stories You Need to See

A roundup of the week’s most newsworthy sports industry press releases from PR Newswire, including PepsiCo’s “Unretirement” campaign and LG’s partnership with the Yankees. NEW YORK, Sept. 1, 2023 /PRNewswire/ — With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire….

Continue Reading 13 Stories You Need to See

NFL, AWS unveil NFL Contact Detection Challenge winner

The NFL and Amazon Web Services reported that the winning entry in its Contact Detection Challenge, a computer vision and machine learning contest to aid in the prediction of injuries, marked a 31% improvement in automatically identifying on-field contact. Nghia Van Ngoc Nguyen, a Vietnamese data scientist now based in…

Continue Reading NFL, AWS unveil NFL Contact Detection Challenge winner

Top Finishers in NFL Data Challenge Improve League’s Ability to Predict Injuries on the Field Using AI

The challenge brought together data scientists from around the world who built machine learning and computer vision models to help the league better measure and analyze the timing, duration and frequency of player contact during NFL games. The models provide insights the league can use to identify which types of…

Continue Reading Top Finishers in NFL Data Challenge Improve League’s Ability to Predict Injuries on the Field Using AI

LaLiga, Serie A, the Scottish Cups, Rainbow Cup an..

LaLiga, Serie A, the Scottish Cups, Rainbow Cup and much more. 4 channels from only 10.99 a month. Sky, Virgin or Player. df76b833ed jalpanl www.kaggle.com/afbasti….ngrap/post-malone-be www.kaggle.com/rabarte….ma/nba-2k12-fatal-er www.kaggle.com/nforenb….irro/top-himnario-ad www.kaggle.com/riterbu….fa/gini-awi-saha-gin www.kaggle.com/brisepe….rsduc/portable-foto- cats slot game ,daruma 88 bet,online casino with quick withdrawal,play 11 in … and win money online; Bertramboxing odds anthony…

Continue Reading LaLiga, Serie A, the Scottish Cups, Rainbow Cup an..

Donanemab Data Anchors Upbeat AAIC

28 Jul 2023 Change was in the air at the Alzheimer’s Association International Conference, held July 16-20 in Amsterdam. With the first treatment in 20 years having just earned traditional approval from the U.S. Food and Drug Administration, another with accelerated approval, and a third with positive Phase 3 data,…

Continue Reading Donanemab Data Anchors Upbeat AAIC

Oral Tau Inhibitor Continues to Show Promise in Alzheimer’s

Treatment with an experimental oral tau aggregation inhibitor, hydromethylthionine mesylate (HMTM), led to a statistically significant reduction in an established biomarker of neurodegeneration in Alzheimer’s disease (AD) in the LUCIDITY phase 3 trial. Blood concentrations of neurofilament light chain (NfL) showed a 93% reduction in change over 12 months in…

Continue Reading Oral Tau Inhibitor Continues to Show Promise in Alzheimer’s

Beyond Biotech podcast 55: Inflammasomes

This week, we’re talking about inflammasome inhibitors with Alan Watt, CEO of NodThera. ​​NodThera announced positive initial data from four subjects in the elderly volunteer stage of its phase Ib/IIa study evaluating the effects of its lead candidate NT-0796 on inflammatory and disease-specific biomarkers in the blood and cerebrospinal fluid…

Continue Reading Beyond Biotech podcast 55: Inflammasomes

Eisai Presents Latest Analysis of Lecanemab’s Effect on Biomarker Changes and Subcutaneous Dosing at The Alzheimer’s Association International Conference (AAIC) 2023

CAMBRIDGE, Mass., and TOKYO, Jul 20, 2023 – (JCN Newswire) – Eisai Co., Ltd. and Biogen Inc. announced today that the results of a detailed analysis of the Phase 3 Clarity AD study demonstrated that lecanemab-irmb (generic name, U.S. brand name: LEQEMBI) treatment showed reductions in amyloid-beta (Abeta) pathology and…

Continue Reading Eisai Presents Latest Analysis of Lecanemab’s Effect on Biomarker Changes and Subcutaneous Dosing at The Alzheimer’s Association International Conference (AAIC) 2023

TauRx’s Hydromethylthionine Mesylate (HMTM) Demonstrates Significant Reduction in Neurodegeneration in Alzheimer’s Disease (AD)

Results from a prespecified analysis of the Phase 3 LUCIDITY trial show reduction in neurodegeneration biomarker (NfL) in AD for people receiving 16 mg/day of HMTM compared to controls HMTM is an oral drug with a strong safety profile Results announced in an oral presentation at the Alzheimer’s Association International…

Continue Reading TauRx’s Hydromethylthionine Mesylate (HMTM) Demonstrates Significant Reduction in Neurodegeneration in Alzheimer’s Disease (AD)

NurOwn trial finds slower ALS progression with lower NfL levels | New Phase 3 study analysis to support therapy’s possible approval

NurOwn, an experimental treatment, significantly lowered neurofilament light chain (NfL) levels in the spinal fluid, a marker of nerve damage, and this seems to predict slower disease progression in amyotrophic lateral sclerosis (ALS) patients. That’s according to a new analysis of Phase 3 clinical trial (NCT03280056) data that examined changes…

Continue Reading NurOwn trial finds slower ALS progression with lower NfL levels | New Phase 3 study analysis to support therapy’s possible approval

NodThera shows reduction in neuroinflammation

NodThera has announced positive, initial data from four subjects in the elderly volunteer stage of its phase Ib/IIa study evaluating the effects of its lead candidate NT-0796 on inflammatory and disease-specific biomarkers in the blood and cerebrospinal fluid (CSF). NodThera is a clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to…

Continue Reading NodThera shows reduction in neuroinflammation

BrainStorm Cell Therapeutics Data Show Treatment with NurOwn Significantly Reduces NfL, a Key Biomarker of Neurodegeneration

New data presented this week at Gordon Research Conference Analysis reinforces NfL levels as predictive of ALS clinical outcomes NEW YORK, July 7, 2023 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, this week presented new biomarker data from the…

Continue Reading BrainStorm Cell Therapeutics Data Show Treatment with NurOwn Significantly Reduces NfL, a Key Biomarker of Neurodegeneration

The Promise and Perils of Antisense Therapies in CNS Diseases

Pictured: shRNA sense and antisense sequences/iStock, Love Employee The recent FDA approval of Biogen’s Qalsody for superoxide dismutase 1 (SOD1)–ALS highlighted the potential for antisense oligonucleotides in central nervous system diseases. But the recent failure of Wave Life Sciences’ WVE-004 in C9orf72–ALS also showed their limitations. Antisense oligonucleotides (ASOs) are…

Continue Reading The Promise and Perils of Antisense Therapies in CNS Diseases

Parkinson’s Disease Drug Slows ALS Progression in Clinical Trial

An early clinical trial headed by researchers at Keio University School of Medicine has shown that the Parkinson’s disease drug ropinirole is safe to use in patients with the fatal motor neuron disease amyotrophic lateral sclerosis (ALS), and delayed disease progression by an average of 27.9 weeks. The study demonstrated…

Continue Reading Parkinson’s Disease Drug Slows ALS Progression in Clinical Trial

Common drug used for Parkinson’s disease could help fight ALS

TOKYO, Japan — A new study reveals that a common drug for treating Parkinson’s disease, ropinirole, can effectively slow the progression of amyotrophic lateral sclerosis (ALS) for over six months. ALS, which has claimed the lives of countless people, including renowned cosmologist Stephen Hawking, gradually causes people to lose muscle…

Continue Reading Common drug used for Parkinson’s disease could help fight ALS

Sanofi drug reduces disease activity in relapsing MS

New data, being presented in a late-breaking session at the 2023 Consortium of Multiple Sclerosis Centers (CMSC) annual meeting, demonstrate that frexalimab, Sanofi’s novel second-generation investigational anti-CD40L antibody, with a unique mechanism of action, significantly reduced disease activity in a phase 2 trial of patients with relapsing multiple sclerosis (MS). …

Continue Reading Sanofi drug reduces disease activity in relapsing MS

Giants’ Brian Daboll treating OTAs like a ‘teaching camp’

This week, New York Giants head coach Brian Daboll began his second round of organized team activities (OTAs) with the team. There’s a big difference in the air from this time last year when everything and almost everyone was new to one another and their surroundings. The Giants entered Phase…

Continue Reading Giants’ Brian Daboll treating OTAs like a ‘teaching camp’

Steelers OTAs Recap Day 2: T.J. Watt returns to Pittsburgh

The Pittsburgh Steelers were back on the field for Organized Team Activities (OTAs) Wednesday, and for those who haven’t been paying attention this isn’t breaking news. The Steelers have been participating in OTAs for the last few months, but Phase 3, which just started, gets the most news. In case…

Continue Reading Steelers OTAs Recap Day 2: T.J. Watt returns to Pittsburgh

Steelers OTAs Recap Day 1: Rookies take center stage at practice

The Pittsburgh Steelers were back on the field for Organized Team Activities (OTAs) Tuesday, and for those who haven’t been paying attention this isn’t breaking news. The Steelers have been participating in OTAs for the last few months, but Phase 3, which just started, gets the most news. In case…

Continue Reading Steelers OTAs Recap Day 1: Rookies take center stage at practice

Saints to hold voluntary OTA’s starting today

This week, the New Orleans Saints will begin “Phase 3” of their voluntary offseason workout programs. The Saints will hold organized team activities (OTA’s) starting today, Tuesday, May 23rd-Thursday May 25th. They will also hold OTA’s on Tuesday, May 30th-Thursday, June 1st and Monday, June 5th-Thursday, June 8th. There will…

Continue Reading Saints to hold voluntary OTA’s starting today

What to Expect from Jets OTAs

“As a coach, you want them all here, all the time,” Saleh said. “Just felt like for him, he’s a very smart individual, very deep and very thoughtful. Personally, and I don’t know if it’s the right thing to say, I was never worried about whether or not he was…

Continue Reading What to Expect from Jets OTAs

Detroit Lions to Begin Phase 3 of Offseason Program

The Detroit Lions are ready to kick off the third phase of the NFL offseason as they commence their OTAs (Other Team Activities) this week. These non-contact practice sessions will take place on Tuesday, Wednesday, and Thursday at the team’s facility in Allen Park. As the team enters this crucial…

Continue Reading Detroit Lions to Begin Phase 3 of Offseason Program

Chiefs Offseason 2023: Phase 3 of OTAs begins on Monday

On Monday, 20 NFL teams — including the Kansas City Chiefs — will begin Phase Three of their offseason programs. During Phase Three, teams may conduct a total of 10 days of voluntary organized team practice activity, or “OTAs”. No live contact is permitted, but 7-on-7, 9-on-7, and 11-on-11 drills…

Continue Reading Chiefs Offseason 2023: Phase 3 of OTAs begins on Monday

Forward ssh-agent socket from login node to worker in slurm

My current solution is to “reverse forward ssh-agent” from worker node to login node: if [[ $(hostname) == login* ]] ; then echo ‘Welcome to login node’ export LOGIN_NODE_NAME=$HOSTNAME else echo ‘Welcome to job node’ ssh -NfL ~/.ssh/$(hostname).sock:$SSH_AUTH_SOCK -o ‘StreamLocalBindUnlink=yes’ -o ‘ExitOnForwardFailure=yes’ $LOGIN_NODE_NAME export SSH_AUTH_SOCK=~/.ssh/$(hostname).sock ssh-add -L >/dev/null 2>&1 &&…

Continue Reading Forward ssh-agent socket from login node to worker in slurm

The fight over EPA Phase 3 emissions regs

When environmental activists talk about trucking, they often talk about diesel fumes spewed faceless corporations and hurting, maybe even killing, innocent children. As such, the level of their opposition to the trucking industry, to the fossil fuels industries, or to any of the carbon-intensive businesses that make American life possible…

Continue Reading The fight over EPA Phase 3 emissions regs

Detroit Lions 2023 OTA offseason workouts and minicamp schedule

As the NFL offseason moves on, here is the Detroit Lions OTA and minicamp schedule. There’s never much of an offseason in the NFL, with some teams having their rookie minicamps this coming weekend and voluntary offseason work having started in April. The Detroit Lions aren’t one of them who…

Continue Reading Detroit Lions 2023 OTA offseason workouts and minicamp schedule

NFL draft results 2023: Why the Patriots selected Keion White, DE, Georgia Tech

As the second round of the 2023 NFL draft continued to move, the New England Patriots stayed home. The war room in Foxborough did so to select Georgia Tech defensive lineman Keion White at No. 46 overall. White would become the fourth edge prospect to leave the board around the…

Continue Reading NFL draft results 2023: Why the Patriots selected Keion White, DE, Georgia Tech

Biogen ALS drug gets FDA ok

The U.S. Food and Drug Administration (FDA) has approved Biogen’s QALSODY (tofersen) 100 mg/15mL injection for the treatment of amyotrophic lateral sclerosis (ALS) in adults who have a mutation in the superoxide dismutase 1 (SOD1) gene.  This indication is approved under accelerated approval based on reduction in plasma neurofilament light…

Continue Reading Biogen ALS drug gets FDA ok

FDA Grants Accelerated Approval for Tofersen

26 Apr 2023 The U.S. Food and Drug Administration has approved tofersen for the treatment of ALS. Developed originally by Ionis Pharmaceuticals and evaluated in clinical trials by Biogen, the antisense oligonucleotide (ASO) targets expression of superoxide dismutase 1. About 2 percent of people with ALS carry pathogenic variants in…

Continue Reading FDA Grants Accelerated Approval for Tofersen

Alphabet : 2023 Q1 Transcript

This transcript is provided for the convenience of investors only, for a full recording please see the Q1 2023 Earnings Call webcast. Alphabet Q1 2023 Earnings Call April 25, 2023 Operator: Welcome, everyone. Thank you for standing by for the Alphabet first quarter 2023 earnings conference call….

Continue Reading Alphabet : 2023 Q1 Transcript

Alphabet Inc. (GOOG) Q1 2023 Earnings Call Transcript

Alphabet Inc. (NASDAQ:GOOG) Q1 2023 Earnings Conference Call April 25, 2023 5:00 PM ET Company Participants Jim Friedland – Director, Investor Relations Sundar Pichai – Chief Executive Officer Philipp Schindler – Chief Business Officer Ruth Porat – Chief Financial Officer Conference Call Participants Brian Nowak – Morgan Stanley Doug Anmuth…

Continue Reading Alphabet Inc. (GOOG) Q1 2023 Earnings Call Transcript

rpubs – Korea

Easy web publishing from R. Write R Markdown documents in RStudio. Share them here on RPubs. (It’s free, and couldn’t be simpler!)Rpubs is an open publishing platform for HTML documents produced using RMarkdown from within RStudio, it provides a simple way to host and share your …Getting Started with RPubs. RStudio…

Continue Reading rpubs – Korea

FDA Places Partial Hold on Evobrutinib Initiation in Newly Enrolled Patients With MS

Because of safety concerns, the FDA has placed a partial clinical hold on the initiation of evobrutinib (EMD Serono), an investigational Bruton’s tyrosine kinase (BTK) inhibitor, in new patients and those with less than 70 days of exposure. EMD Serono noted that this decision does not impact the status of…

Continue Reading FDA Places Partial Hold on Evobrutinib Initiation in Newly Enrolled Patients With MS

Artificial intelligence designs its first robustly functional gene from scratch

skralyx’s spirit animal Most of us have conflicted feelings about artificial intelligence.  Is it awesome, is it nefarious, or is it eerie?  Regardless, it is increasingly understood to be very powerful.  That’s been magnified recently in our everyday conversational lives with online tools like ChatGPT.  There really is no going…

Continue Reading Artificial intelligence designs its first robustly functional gene from scratch

A Trem2R47H mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques | Molecular Neurodegeneration

The Trem2 R47H NSS mutation promotes loss of oligodendrocyte gene expression in response to cuprizone treatment. Results of previous studies of mice with the Trem2R47H missense mutation introduced via CRISPR suggested that it acts as a near-complete loss of function, recapitulating phenotypes seen in Trem2 knock-out (KO) mice [34, 36]….

Continue Reading A Trem2R47H mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques | Molecular Neurodegeneration

rpubs – D.Koreanba

Easy web publishing from R. Write R Markdown documents in RStudio. Share them here on RPubs. (It’s free, and couldn’t be simpler!)Rpubs is an open publishing platform for HTML documents produced using RMarkdown from within RStudio, it provides a simple way to host and share your …Getting Started with RPubs. RStudio…

Continue Reading rpubs – D.Koreanba

FINALISTS NAMED IN 5TH ANNUAL NFL BIG DATA BOWL POWERED BY AWS

​ Over 400 individuals participated in this year’s edition, a record high for the Big Data Bowl competition New York, NY (February 16, 2023) – The National Football League announced today the finalists for the fifth annual Big Data Bowl powered by Amazon Web Services (AWS). The annual sports analytics…

Continue Reading FINALISTS NAMED IN 5TH ANNUAL NFL BIG DATA BOWL POWERED BY AWS

Alphabet (GOOGL) Q4 2022 Earnings Call Transcript

Image source: The Motley Fool. Alphabet (GOOGL -2.75%)Q4 2022 Earnings CallFeb 02, 2023, 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Welcome, everyone. Thank you for standing by for the Alphabet fourth quarter 2022 earnings conference call. At this time, all participants are in a listen-only…

Continue Reading Alphabet (GOOGL) Q4 2022 Earnings Call Transcript

2022, a Year in Review

15 Jan 2023 Part 1 of 2The year 2022 was a turning point in Alzheimer’s research. It began with the Aduhelm debacle fresh on people’s mind. It ended with reassurance that amyloid removal indeed helps people with the disease, when lecanemab’s Phase 3 data showed a slowing of cognitive decline….

Continue Reading 2022, a Year in Review

Solved Use package ‘ggplot2’ to generate all the graplis in

Transcribed image text: Use package ‘ggplot2’ to generate all the graplis in HW4. 1. Stock Prices: – Check out the yahoo webpage of historical stock price data for Netflix (NFLX): finance. yahoo.com/quote/NFL X/history? p=NFLX ). – Change the range of Date from 01/01/2021 to 09/30/2021. Click on “Apply” before “Download”….

Continue Reading Solved Use package ‘ggplot2’ to generate all the graplis in

The Best Sports APIs That Developers Can Use

Sports API is a network that allows two services and applications to give all data connected to sports across all matches, such as score updates, player details, match details, and rankings, Fantasy points, among other things. Sports APIs are multi-disciplinary, which means they may supply a wide range of sports-related…

Continue Reading The Best Sports APIs That Developers Can Use

Aaron Rodgers apologises to Shailene Woodley amid break-up rumours

NFL Player Aaron Rodgers has recently spoken in length about his relationship with actor Shailene Woodley, addressing how criticism of his COVID-19 vaccination status has affected his loved ones. According to The Hollywood Reporter, both stars confirmed their engagement last year, although some media outlets recently reported that the…

Continue Reading Aaron Rodgers apologises to Shailene Woodley amid break-up rumours

NFL Biomarker Unsuitable to Measure CMT1A Outcomes, Study Shows

Blood levels of the protein neurofilament light chain (NFL), a biomarker of several neurological disorders, may not be suitable to measure outcomes in patients with Charcot-Marie-Tooth disease type 1A (CMT1A), a recent study suggests. The study, “A longitudinal and cross-sectional study of plasma neurofilament light chain concentration in Charcot-Marie-Tooth disease,”…

Continue Reading NFL Biomarker Unsuitable to Measure CMT1A Outcomes, Study Shows

r markdown – Cant get r code to run in kaggle notebook

So I’m competing in the NFL Big Data Bowl hosted by Kaggle and I’m having trouble uploading both r script and rmd into kaggle. I keep getting parse errors that I can’t seem to get around. I’ve even tried copy pasting code from other peoples code from similar notebooks but…

Continue Reading r markdown – Cant get r code to run in kaggle notebook